Therapeutic Drugs Business Unit


Pletaal, discovered by Otsuka, inhibits platelet aggregation and has peripheral vasodilator effects. In Japan it was launched in 1988 for the treatment of symptoms associated with chronic arterial obstruction and was also approved in 2003 for prevention of recurrent cerebral infarction.
Pletaal tablets 100mg and 50mg were launched in Egypt in 2004 and 2005 respectively

CopyRight @ OTSUKA 2020
Powered By : Idea World Web